84 related articles for article (PubMed ID: 4836677)
1. A controlled evaluation of 5-fluorouracil utilizing a single injection technique.
Ahmann DL; Moertel CG; Bisel HF; Hahn RG; Schutt AJ; Dines DE
Oncology; 1974; 29(2):166-71. PubMed ID: 4836677
[No Abstract] [Full Text] [Related]
2. Oral administration of fluorouracil. A preliminary trial.
Nadler SH
Arch Surg; 1968 Oct; 97(4):654-6. PubMed ID: 5678137
[No Abstract] [Full Text] [Related]
3. Combination chemotherapy in gastrointestinal cancer.
Reitemeier RJ; Moertel CG; Hahn RG
Cancer Res; 1970 May; 30(5):1425-8. PubMed ID: 4246651
[No Abstract] [Full Text] [Related]
4. Treatment of cancer with weekly intravenous 5-fluorouracil. Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG).
Jacobs EM; Reeves WJ; Wood DA; Pugh R; Braunwald J; Bateman JR
Cancer; 1971 Jun; 27(6):1302-5. PubMed ID: 5088208
[No Abstract] [Full Text] [Related]
5. Phase II evaluation of BCNU and 5-FU in gastrointestinal carcinomas.
Tormey DC; Gailani S; Leone L
Oncology; 1974; 29(3):244-8. PubMed ID: 4415043
[No Abstract] [Full Text] [Related]
6. 5-fluorouracil intravenous infusion for 48 hours, repeated every two weeks.
Hill GJ; Grage TB; Wilson W; Ansfield FJ
J Surg Oncol; 1972; 4(1):60-70. PubMed ID: 5033956
[No Abstract] [Full Text] [Related]
7. Cyclophosphamide therapy in patients with advancing breast cancer following adrenalectomy and 5-fluorouracil.
Piro AJ; Wilson RE; Nevinny HB
Cancer; 1971 Jun; 27(6):1342-5. PubMed ID: 5088210
[No Abstract] [Full Text] [Related]
8. Experience with ftorafur treatment in breast cancer.
Karev NI; Blokhina NG; Vozny EK; Pershin MP
Neoplasma; 1972; 19(4):347-50. PubMed ID: 5054534
[No Abstract] [Full Text] [Related]
9. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Chemother Rep; 1972 Feb; 56(1):95-101. PubMed ID: 5030811
[No Abstract] [Full Text] [Related]
10. Toxicity studies of fluorouracil used with adrenalectomy in breast cancer.
Piro AJ; Wilson RE; Hall TC; Aliapoulios MA; Nevinny HB; Moore FD
Arch Surg; 1972 Jul; 105(1):95-9. PubMed ID: 5031606
[No Abstract] [Full Text] [Related]
11. A comparison of 5-fluorouracil administered by slow infusion and rapid injection.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Res; 1972 Dec; 32(12):2717-9. PubMed ID: 4566290
[No Abstract] [Full Text] [Related]
12. Basal-cell carcinoma. A case unmasked by systemic fluorouracil therapy.
Scialla SJ; Miskoff RA
JAMA; 1976 May; 235(22):2416-7. PubMed ID: 946650
[No Abstract] [Full Text] [Related]
13. A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas.
Moertel CG; Rubin J; O'Connell MJ; Schutt AJ; Wieand HS
J Clin Oncol; 1986 Jul; 4(7):1053-7. PubMed ID: 3014083
[TBL] [Abstract][Full Text] [Related]
14. Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinoside.
Gailani S; Holland JF; Falkson G; Leone L; Burningham R; Larsen V
Cancer; 1972 May; 29(5):1308-13. PubMed ID: 4623252
[No Abstract] [Full Text] [Related]
15. The metabolism and pharmacology of 5-fluorouracil.
Miller E
J Surg Oncol; 1971; 3(3):309-15. PubMed ID: 4942414
[No Abstract] [Full Text] [Related]
16. Radiation plus 5-fluorouracil (NSC-19893): clinical demonstration of an additive effect in bronchogenic carcinoma.
Cohen JL; Krant MJ; Shnider BI; Matias PI; Horton J; Baxter D
Cancer Chemother Rep; 1971 Jun; 55(3):253-8. PubMed ID: 5115846
[No Abstract] [Full Text] [Related]
17. A clinical study of fluorouracil.
Nadler SH; Moore GE
Surg Gynecol Obstet; 1968 Dec; 127(6):1210-4. PubMed ID: 4882472
[No Abstract] [Full Text] [Related]
18. 5-fluorouracil given once weekly: comparison of intravenous and oral administration.
Bateman JR; Pugh RP; Cassidy FR; Marshall GJ; Irwin LE
Cancer; 1971 Oct; 28(4):907-13. PubMed ID: 5111743
[No Abstract] [Full Text] [Related]
19. Iv methyl-CCNU and ftorafur with or without methanol-extracted residue of BCG for metastatic adenocarcinoma of the colon.
Diggs CH; Wiernik PH; Smyth AC
Cancer Treat Rep; 1977 Nov; 61(8):1581-3. PubMed ID: 336200
[No Abstract] [Full Text] [Related]
20. VP-16 and adriamycin in patients with advanced breast cancer.
Vaughn CB; Maniscalco-Greb E; Lockhard C; Groshko G; Enochs K; Duffin H; Demitrish M
Am J Clin Oncol; 1982 Oct; 5(5):505-9. PubMed ID: 6897491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
